Molecular-Docking Study of quinazolin-4(3H)-one derivatives against GABAa Receptor Signifies the Novel Approach to Epilepsy Treatment. International Journal of Pharmaceutical Sciences and Drug Research, [S. l.], v. 12, n. 5, p. 572–575, 2020. DOI: 10.25004/IJPSDR.2020.120521. Disponível em: https://ijpsdronline.com/index.php/journal/article/view/1817.. Acesso em: 21 sep. 2025.